Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration

Summary Background  Finasteride, a competitive inhibitor of the enzyme 5α‐reductase II, is widely used as a medical treatment for patients with male‐pattern baldness (MPB), which is affected by the distribution of androgenic steroids. It is also notable that the androgenic effect in MPB is different...

Ausführliche Beschreibung